Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study | MicrobiomeTrials← Back to trialsNCT07634263
Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-07-01Est. Completion: 2027-06-30
Enrollment target: 50 participants Locations- Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark
- Odense University Hospital, Odense, Denmark
- Sjællands Universitets Hospital, Roskilde, Denmark
ContactKristina Nørskov, RN, PhD
Other microbiome trials you might be interested in
Malignant Lymphoma - LymphoplasmacyticMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma
Cell- and antibody-based therapies, including chimeric antigen receptor T-cell (CAR-T) therapy and bispecific antibodies…
Aarhus, DenmarkEst. completion Mar 31, 2032
Waldenstrom MacroglobulinemiaMultiple MyelomaChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaLymphoplasmacytic LymphomaMarginal Zone Lymphoma
Mantle Cell Lymphoma
Diffuse Large B Cell Lymphoma
Central Nervous System Lymphoma
Part A of this study evaluates iopofosine I 131 (CLR 131) in patients with select B-cell malignancies (multiple myeloma(…
Los Angeles, United StatesEst. completion Jun 22, 2026